Abiopharma

Kymera Therapeutics Inc (KYMR) Announces Executive and Board Changes Kymera Therapeutics Inc (KYMR) announced changes to its leadership team and board of directors. Directors or was appointed. The position includes: Class II, Governance Committee, Compensation Committee, Audit Committee, Nominating and Corporate Governance Committee. The change is effective as of July 1, 2022. Executive Changes Details:

• Personnel Involved: Directors or, Certain Officers
• Actions: Appointed
• Committee Assignments: Governance Committee, Compensation Committee, Audit Committee, Nominating and Corporate Governance Committee
• Board Classification: Class II